Newron Interest Expense from 2010 to 2026
| NWRN Stock | CHF 18.68 0.24 1.30% |
Interest Expense | First Reported 2004-12-31 | Previous Quarter 4.4 M | Current Value 1.9 M | Quarterly Volatility 772.6 K |
Check Newron Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Newron Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Selling General Administrative of 4.6 M or Other Operating Expenses of 21.2 M, as well as many indicators such as Price To Sales Ratio of 3.76, Dividend Yield of 0.0 or PTB Ratio of 115. Newron financial statements analysis is a perfect complement when working with Newron Pharmaceuticals Valuation or Volatility modules.
Newron | Interest Expense |
The evolution of Interest Expense for Newron Pharmaceuticals SpA provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Newron Pharmaceuticals compares to historical norms and industry peers.
Latest Newron Pharmaceuticals' Interest Expense Growth Pattern
Below is the plot of the Interest Expense of Newron Pharmaceuticals SpA over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Newron Pharmaceuticals' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Newron Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Interest Expense | 10 Years Trend |
|
Interest Expense |
| Timeline |
Newron Interest Expense Regression Statistics
| Arithmetic Mean | 1,729,853 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 121.85 | |
| Mean Deviation | 1,905,238 | |
| Median | 157,000 | |
| Standard Deviation | 2,107,846 | |
| Sample Variance | 4.4T | |
| Range | 5.3M | |
| R-Value | 0.90 | |
| Mean Square Error | 904.3B | |
| R-Squared | 0.81 | |
| Slope | 375,485 | |
| Total Sum of Squares | 71.1T |
Newron Interest Expense History
About Newron Pharmaceuticals Financial Statements
Newron Pharmaceuticals investors use historical fundamental indicators, such as Newron Pharmaceuticals' Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Newron Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Interest Expense | 5 M | 5.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Newron Stock Analysis
When running Newron Pharmaceuticals' price analysis, check to measure Newron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Newron Pharmaceuticals is operating at the current time. Most of Newron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Newron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Newron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Newron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.